UCL Division of Medicine: IMPACT Studentship Programme

UCL Division of Medicine: IMPACT Studentship Programme (x 6)

University College London

Duration of Studentship: Three years
Stipend: £15,363 pa (2009-10 rates)
Vacancy Information
The Division of Medicine invites applications for research studentships starting in October 2010.  This is a new three-year programme in Biomedical Science offering six outstanding students the opportunity to study in a world-class interdisciplinary environment within departments pursuing a highly acclaimed international research agenda.   The overall aim of the programme is to take lab science closer to patient benefit.
Successful candidates will select a laboratory and project from a portfolio of projects based in one of the Research Departments of the Division.  They will also have the opportunity to benefit from expertise from across the Division and, depending on the nature of the project proposed, work across Departments or with a co-supervisor from another Division or Institute in School of Medical and Life Sciences (SLMS) or from another Faculty in UCL.
Studentship Description
A list of indicative projects and supervisors is available here:http://www.ucl.ac.uk/medicine/teaching/pg/research_projects
This is not intended to be a prescriptive list of the projects that might be possible: the Division wishes to appoint the best students wherever their research interests lie, provided the project and supervisory team can be shown to satisfy the terms of the scheme at UCL. Please refer to the Division of Medicine website for for more information on research areas and groups.
Eligibility:
Applicants should have (or expect to obtain) a first or upper second class degree in an appropriate discipline. An MSc in a relevant subject is desirable.  These studentships are restricted to candidates eligible to pay Home/EU rates.
Application Process
Applications should include a CV, an indication of the topic for which the candidate is applying, and a statement of research experience and interests. Applications by email are preferred.  Please include a contact telephone number and an email address. Applications should be addressed to Mrs Sonja Read: sonja.read@ucl.ac.uk
If you wish to discuss possible research topics and opportunities, please contact the Divisional Manager Julie Radcliffe on j.radcliffe@ucl.ac.uk
Closing date for this studentship is 9th April 2010

BBSRC Industrial Studentship with Critical Pharmaceutical Ltd

Investigation Of A Novel Absorption Promoter For The Transmucosal Delivery Of Drugs

University of Nottingham - School of Pharmacy

The project will investigate a novel absorption promoter for the transmucosal delivery of drugs that is of interest to the industrial sponsor. This project will focus on a number of key areas including: evaluation of the physico-chemical properties of the absorption promoter formulations and identify essential characteristics, investigate its mechanisms of action using appropriate cell culture models and identifying synergistic effects with other known absorption promoters.
This PhD project will be supervised in collaboration with the academic supervisor (Dr S Stolnik) and industrial co-sponsor, Critical Pharmaceuticals Ltd (Dr F Jordan) and will provide the student with training in drug delivery, physicochemical characterisation, cell culture and related analytical and imaging methods, along with the opportunity to work in both an academic and industrial research surrounding.
Critical Pharmaceuticals is a biotechnology company with proprietary drug delivery technologies for injectable sustained release and nasal delivery of challenging drugs including proteins and peptides.
For more information see: http://www.criticalpharmaceuticals.com/.
The nasal route of delivery can be exploited for the systemic delivery of drugs such as small molecular weight polar drug, peptides and proteins that are not easily administered via other routes than by injection.
Despite the large surface area of the nasal cavity and extensive blood supply, absorption of polar molecules, peptides and proteins is low and can be greatly improved if administered in conjunction with an absorption promoting agent.
The enhancer systems work by a number of mechanisms, however, studies have shown that there is a direct correlation between the absorption enhancing effect obtained and the damage caused to the nasal membrane. It is therefore important to discover and evaluate new absorption promoter systems. Critical Pharmaceuticals is a small specialty pharmaceutical company and have developed a safe and effective nasal drug delivery platform based on an absorption promoter called CriticalSorb^TM.
This is a four year BBSRC studentship co-funded with industry (Critical Pharmaceuticals Ltd).
To learn more about the project and/or to express an interest please contact Dr S Stolnik, Email: Snjezana.Stolnik@Nottingham.ac.uk, Dr F Jordan, Email: Faron.Jordan@Criticalpharmaceuticals.com or Mrs C MacLeod, tel: 0115 846 6250, Email: Christina.Macleod@Nottingham.ac.uk.
Please quote ref. SCI/807.
This studentship is open until filled.
For all our vacancies and more about working at the University of Nottingham see: http://jobs.nottingham.ac.uk/.